Find, compare & contact
Obinutuzumab API Manufacturers
Contact suppliers
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Obinutuzumab is listed?
Join our notification list by following this page.
Join our notification list by following this page.
List your company
Are you a supplier of Obinutuzumab or other APIs and are you looking to list your company on Pharmaoffer?
Click the button below to find out more
Click the button below to find out more
Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?
Click the button below to switch over to the contract services area of Pharmaoffer.
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Obinutuzumab API 949142-50-1?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Obinutuzumab. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Obinutuzumab
- Synonyms:
- Afutuzumab
- Cas Number:
- 949142-50-1
- DrugBank number:
- DB08935
- Unique Ingredient Identifier:
- O43472U9X8
About Obinutuzumab
Some technical information about this product: Obinutuzumab is a humanized monoclonal antibody used as a combination treatment with chlorambucil to treat patients with untreated chronic lymphocytic leukemia. It was approved by the FDA in November 2013 and is marketed under the brand name Gazyva. There is a black box warning of fatal Hepatitis B Virus (HBV) reactivation and fatal Progressive Multifocal Leukoencephalopathy (PML).
You can ask the supplier about all relevant certificates for the product such as CoA, Safety Data Sheet and DMF.
